Conmed

Forecast & Rating7 analysts currently cover Conmed, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $45.50, about 3.2% downside from the current price of $46.98. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 34.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Conmed's outlook. Data as of Jul 30, 2026; for reference only and not investment advice.